rs706584

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000411922.5(ALG3):​n.*943T>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.225 in 1,588,802 control chromosomes in the GnomAD database, including 41,130 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.24 ( 4372 hom., cov: 32)
Exomes 𝑓: 0.22 ( 36758 hom. )

Consequence

ALG3
ENST00000411922.5 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.158

Publications

16 publications found
Variant links:
Genes affected
ALG3 (HGNC:23056): (ALG3 alpha-1,3- mannosyltransferase) This gene encodes a member of the ALG3 family. The encoded protein catalyses the addition of the first dol-P-Man derived mannose in an alpha 1,3 linkage to Man5GlcNAc2-PP-Dol. Defects in this gene have been associated with congenital disorder of glycosylation type Id (CDG-Id) characterized by abnormal N-glycosylation. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Nov 2008]
VWA5B2 (HGNC:25144): (von Willebrand factor A domain containing 5B2)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 3-184242464-A-C is Benign according to our data. Variant chr3-184242464-A-C is described in ClinVar as Benign. ClinVar VariationId is 259884.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALG3NM_005787.6 linkc.*50T>G 3_prime_UTR_variant Exon 9 of 9 ENST00000397676.8 NP_005778.1 Q92685-1
VWA5B2NM_001390846.1 linkc.*426A>C downstream_gene_variant ENST00000691901.1 NP_001377775.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALG3ENST00000397676.8 linkc.*50T>G 3_prime_UTR_variant Exon 9 of 9 1 NM_005787.6 ENSP00000380793.3 Q92685-1
VWA5B2ENST00000691901.1 linkc.*426A>C downstream_gene_variant NM_001390846.1 ENSP00000509115.1 Q8N398

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
35965
AN:
151998
Hom.:
4365
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.291
Gnomad AMI
AF:
0.157
Gnomad AMR
AF:
0.213
Gnomad ASJ
AF:
0.164
Gnomad EAS
AF:
0.190
Gnomad SAS
AF:
0.227
Gnomad FIN
AF:
0.195
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.225
Gnomad OTH
AF:
0.239
GnomAD2 exomes
AF:
0.210
AC:
44719
AN:
213090
AF XY:
0.210
show subpopulations
Gnomad AFR exome
AF:
0.283
Gnomad AMR exome
AF:
0.162
Gnomad ASJ exome
AF:
0.168
Gnomad EAS exome
AF:
0.188
Gnomad FIN exome
AF:
0.191
Gnomad NFE exome
AF:
0.222
Gnomad OTH exome
AF:
0.208
GnomAD4 exome
AF:
0.224
AC:
321910
AN:
1436684
Hom.:
36758
Cov.:
31
AF XY:
0.223
AC XY:
159129
AN XY:
712494
show subpopulations
African (AFR)
AF:
0.292
AC:
9703
AN:
33210
American (AMR)
AF:
0.169
AC:
6730
AN:
39786
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
4352
AN:
25646
East Asian (EAS)
AF:
0.166
AC:
6496
AN:
39050
South Asian (SAS)
AF:
0.224
AC:
18597
AN:
82906
European-Finnish (FIN)
AF:
0.190
AC:
9924
AN:
52154
Middle Eastern (MID)
AF:
0.232
AC:
1256
AN:
5422
European-Non Finnish (NFE)
AF:
0.229
AC:
251688
AN:
1098902
Other (OTH)
AF:
0.221
AC:
13164
AN:
59608
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
11623
23246
34869
46492
58115
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8714
17428
26142
34856
43570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.237
AC:
35991
AN:
152118
Hom.:
4372
Cov.:
32
AF XY:
0.232
AC XY:
17250
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.291
AC:
12067
AN:
41464
American (AMR)
AF:
0.213
AC:
3258
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.164
AC:
567
AN:
3466
East Asian (EAS)
AF:
0.189
AC:
977
AN:
5164
South Asian (SAS)
AF:
0.226
AC:
1090
AN:
4824
European-Finnish (FIN)
AF:
0.195
AC:
2064
AN:
10610
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.224
AC:
15262
AN:
67984
Other (OTH)
AF:
0.237
AC:
500
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1405
2810
4214
5619
7024
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
372
744
1116
1488
1860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.227
Hom.:
1869
Bravo
AF:
0.239
Asia WGS
AF:
0.235
AC:
822
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALG3-congenital disorder of glycosylation Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
3.8
DANN
Benign
0.45
PhyloP100
0.16
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs706584; hg19: chr3-183960252; COSMIC: COSV56611079; COSMIC: COSV56611079; API